This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Vision-Sciences Announces Exclusive Urology Supply Agreement With Stryker

ORANGEBURG, N.Y., Sept. 22, 2010 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI) ("Vision-Sciences") announced today that it has signed a three year agreement under which Vision-Sciences will become the exclusive supplier to Stryker Corporation (NYSE:SYK) ("Stryker"), through its Endoscopy division, of Stryker-branded flexible video and fiber cystoscopes. These cystoscopes will employ Vision-Sciences' patented slide-on EndoSheath® technology. Vision-Sciences will also supply Stryker with flexible ureteroscopes upon launch of this product line, expected to occur during calendar 2011.

Under the terms of the agreement, Stryker will pay Vision-Sciences a prepayment of $5 million, of which $2.5 million is due at signing, and $2.5 million is due on or before March 31, 2011. Vision-Sciences will apply the payment to amounts due from Stryker for purchases of scopes and EndoSheath technology until the $5 million is exhausted. Stryker will thereafter continue to pay Vision-Sciences for products supplied.

Stryker will initially have the exclusive rights to distribute the products in North and Latin America, South America, China and Japan including all cystoscopes, urology EndoSheath technology, and ureteroscopes manufactured by Vision-Sciences. 

Lewis C. Pell, Chairman of Vision-Sciences, stated, "We are extremely pleased to have Stryker as our marketing and distribution partner for our urological line of products. Stryker is one of the preeminent endoscopy companies in the world and is highly skilled in selling capital equipment and disposable products. We believe that our innovative EndoSheath system, coupled with Stryker's highly professional and established sales and marketing forces, will result in effective market penetration for the products and improvement in our top-line revenue."

Mr. Pell added, "This transaction will allow us to focus on increasing sales of our airway-related products, including our bronchoscopes and trans-nasal esophagoscopes and related EndoSheath technology and our ENT (ear, nose and throat) endoscopes. We can focus our development on our spine video endoscope, which will be used to give direct visualization to surgeons during minimally invasive spine surgery procedures. Vision-Sciences possesses a platform technology for endoscopic, minimally invasive procedures, which the healthcare market is rapidly moving toward."

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,164.95 -251.90 -1.45%
S&P 500 1,994.99 -26.26 -1.30%
NASDAQ 4,635.24 -48.1670 -1.03%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs